252 results on '"Green, Adam L."'
Search Results
2. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
3. Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics
4. A review calling for research directed at early detection of childhood cancers: The clinical, scientific, and economic arguments for population screening and surveillance
5. Vaccination practices of pediatric oncologists from eight states
6. Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening
7. Investigation of white blood cell characteristics in cerebrospinal fluid samples at pediatric brain tumor diagnosis
8. Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups
9. Demographic and socioeconomic disparities in pediatric cancer in the United States: Current knowledge, deepening understanding, and expanding intervention
10. Sociodemographic and Socioeconomic Factors Correlate with Late-Stage Pediatric Hodgkin Lymphoma and Rhabdomyosarcoma: A Report from the Children's Oncology Group Registries.
11. Sociodemographic Disparities in Presentation and Survival of Pediatric Bone Cancers
12. PRMT5 maintains tumor stem cells to promote pediatric high-grade glioma tumorigenesis
13. Investigating the Impact of Tumor Biology and Social Determinants on Time to Diagnosis and Stage at Presentation of Wilms Tumor
14. Sociodemographic Disparities in Presentation and Survival of Pediatric Bone Cancers
15. A novel, germline, deactivating CBL variant p.L493F alters domain orientation and is associated with multiple childhood cancers
16. Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma
17. Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B
18. Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma
19. BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway
20. Targetable molecular alterations in congenital glioblastoma
21. Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma.
22. Early death from childhood cancer: First medical record‐level analysis reveals insights on diagnostic timing and cause of death
23. Mapping pediatric brain tumors to their origins in the developing cerebellum
24. Oncogenic GOPC-ROS1 Fusion Identified in a Congenital Glioblastoma Case
25. Population-Based Analysis of Demographic and Socioeconomic Disparities in Pediatric CNS Cancer Survival in the United States
26. A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease
27. Identifying patterns of neurocognitive dysfunction through direct comparison of children with leukemia, central nervous system tumors, and sickle cell disease
28. Supp. Table 2 from Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma
29. Supp. Figures from Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma
30. Supp. Table 3 from Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma
31. Data from Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma
32. Supp. Table 1 from Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma
33. Supp. Methods from Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma
34. Supplementary Data from A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
35. Melanoma
36. Langerhans Cell Histiocytosis
37. Effect of early-stage autophagy inhibition in BRAFV600E autophagy-dependent brain tumor cells
38. Risk of early death in adolescents and young adults with cancer: a population-based study
39. MRI-guided focused ultrasound blood–brain barrier opening increases drug delivery and efficacy in a diffuse midline glioma mouse model
40. Identifying Patterns of Neurocognitive Dysfunction through Direct Comparison of Patients with Leukemia, CNS Tumors, and Sickle Cell Disease
41. Correction: BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway
42. Population-based analysis of radiation-induced gliomas after cranial radiotherapy for childhood cancers
43. Successful Treatment of Recurrent Li-Fraumeni Syndrome-related Choroid Plexus Carcinoma
44. Tumor treating fields in pediatric high-grade glioma
45. Radiation Therapy for Young Children Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant for Primary Brain Tumors
46. A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
47. Pediatric Brainstem Gliomas: New Understanding Leads to Potential New Treatments for Two Very Different Tumors
48. Mapping pediatric brain tumors to their origins in the developing cerebellum
49. Therapeutic Targeting of Exportin-1 in Childhood Cancer
50. Abstract P162: Phase 1 trial of selinexor in children and adolescents with recurrent/refractory solid and CNS tumors (ADVL1414): A Children’s Oncology Group Phase 1 Consortium trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.